Oramed Pharmaceuticals Inc.
Status: Publicly traded
Direct answer
Oramed Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker ORMP.
Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully completed Phase II clinical...
Can you invest in Oramed Pharmaceuticals Inc.?
Yes. Oramed Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker ORMP.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Oramed Pharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.